Shawver Laura (CIK 1551891) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-04-08). Recent activity: Buy SPRY (22,509 shares), Buy SPRY (27,493 shares), Sell SPRY (50,002 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-08 | ARS Pharmaceuticals, Inc. (SPRY) | Director | Buy | 22,509 | $109,169 |
| 2025-04-08 | ARS Pharmaceuticals, Inc. (SPRY) | Director | Buy | 27,493 | $133,341 |
| 2025-04-08 | ARS Pharmaceuticals, Inc. (SPRY) | Director | Sell | 50,002 | $615,025 |
来源：SEC Form 4 申报文件 · 截至 2025-04-08